Flow Dysfunction of Hemodialysis Vascular Access

NAActive, not recruitingINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Dialysis Access MalfunctionHemodialysis Access FailureHemodialysis Fistula ThrombosisVascular Access Malfunction
Interventions
DIAGNOSTIC_TEST

Vascular access monitoring

Patients are referred for correction of the underlying stenosis when clinical signs of flow dysfunction are present. These include physical signs, problems during dialysis, or an unexplained, sustained fall in dialysis adequacy. Patients will be referred for correction of the underlying stenosis when clinical signs of flow dysfunction are present.

DIAGNOSTIC_TEST

Vascular access blood flow measurement

Monthly surveillance of vascular access blood flow volume by ultrasound dilution measurements during hemodialysis sessions. Patients will be referred for correction of the underlying stenosis at an access flow volume \<500mL/min.

Trial Locations (13)

Unknown

Diapriva - Dialyse Centrum Amsterdam, Amsterdam

OLVG, Amsterdam

Deventer Ziekenhuis, Deventer

Medisch Spectrum Twente, Enschede

Spaarne Gasthuis, Haarlem

Zuyderland Medisch Centrum, Heerlen

Leids Universitair Medisch Centrum, Leiden

Maastricht UMC+, Maastricht

Bravis Ziekenhuis, Roosendaal

Franciscus Gasthuis & Vlietland, Rotterdam

Universitair Medisch Centrum Utrecht, Utrecht

Maxima Medisch Centrum, Veldhoven

Isala Klinieken, Zwolle

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Maastricht University Medical Center

OTHER